Drug Type Prophylactic vaccine |
Synonyms- |
Target |
Action agonists |
Mechanism HCV E2 agonists(HCV E2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | United States | 15 Apr 2020 |